Cladribine Injection 1 mg (Cladribine SOLUTION) 1 MG

Cladribine Injection 1 mg is a medication used for certain medical conditions. This intravenous solution is manufactured by Generic Medical Partners Inc. in Canada.

Strength

1 MG

Manufacturer / TM Owner

GENERIC MEDICAL PARTNERS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cladribine Injection is typically used in the treatment of specific medical conditions, often related to immune system disorders. It is administered intravenously and may be prescribed for conditions where other treatments have not been effective. The primary use of Cladribine Injection is to target and manage certain types of immune system-related disorders.

Side Effects

Common effects of Cladribine Injection may include fatigue, nausea, and fever. Some individuals might experience more severe side effects, and it is important to monitor for any unusual symptoms. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Cladribine Injection should be handled with care and administered under medical supervision. It is important to follow the prescribed dosage and administration guidelines. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Cladribine Injection may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also interact with Cladribine Injection.

References

Frequently Asked Questions

Cladribine Injection is used to treat certain immune system-related disorders. It is typically prescribed when other treatments have not been effective.

Cladribine Injection is administered intravenously by a healthcare professional. It should be given under medical supervision.

Common side effects may include fatigue, nausea, and fever. More severe side effects are possible, and any unusual symptoms should be reported to a healthcare provider.

Cladribine Injection may interact with other medications, especially those that affect the immune system. Always consult a healthcare provider before combining treatments.

Cladribine Injection is manufactured by Generic Medical Partners Inc. in Canada.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.